cp 65,526 has been researched along with tariquidar in 1 studies
| Studies (cp 65,526) | Trials (cp 65,526) | Recent Studies (post-2010) (cp 65,526) | Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) |
|---|---|---|---|---|---|
| 65 | 1 | 5 | 210 | 16 | 138 |
| Protein | Taxonomy | cp 65,526 (IC50) | tariquidar (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 0.0643 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.0841 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 7.1 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.2363 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambudkar, SV; Barnett, D; Bates, SE; Finley, EM; Fojo, T; Oldham, RK; Robey, RW; Shukla, S | 1 |
1 trial(s) available for cp 65,526 and tariquidar
| Article | Year |
|---|---|
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
Topics: Adenosine Triphosphatases; Alkaloids; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Factors; Biological Transport; Cell Line; Cell Line, Tumor; Cyclosporins; Depsipeptides; Fluorescent Dyes; Fluorouracil; Humans; Insecta; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Prazosin; Quinolines; Rhodamine 123; Verapamil; Vinblastine | 2008 |